BiotechTube
Home/Rani Therapeutics/Talat Imran
TI

Talat Imran

Chief Executive Officer

Rani Therapeutics

Therapeutic Areas

OsteoporosisInflammatory DiseasesImmunology

Rani Therapeutics Pipeline

DrugIndicationPhase
RT-102Osteoporosis (Parathyroid Hormone Analog)Phase 1
RT-111Inflammatory Diseases (Ustekinumab Biosimilar)Phase 1

Leadership Team at Rani Therapeutics

MI
Mir Imran
Founder and Chairman
View full Rani Therapeutics profile